Oncology PracticeCirculating Tumor DNA Hints at BC Recurrence RiskJuly 24, 2024ASCO Breast CancerBreast Cancer
Oncology PracticeGreater Transparency of Oncologists’ Pharma Relationships NeededJuly 22, 2024Practice ManagementPatient & Survivor CarePreventive CareBreast CancerCNS/Brain CancerDLBCLDiversity in Medicine
Oncology PracticeCognitive Decline Minimal After Endocrine + CDK4/6 Inhibition in BCJuly 17, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Hematology NewsASCO 2024: An Expert’s Top Hematology HighlightsJuly 11, 2024AMLCMLPatient & Survivor Care
Oncology PracticeEribulin Similar to Taxane When Paired With Dual HER2 Blockade in BCJuly 10, 2024Breast CancerMetastatic Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticePFS Benefits Seen With Palbociclib + Endocrine Therapy in Breast CancerJuly 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeNew ADC results mixed in metastatic breast cancerJuly 8, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeAdjuvant Avelumab Benefits Seen in High Risk, Triple Negative BCJuly 8, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeClinical Controversy: Standard Dose or Baby TAM for Breast Cancer Prevention?July 5, 2024Breast CancerPatient & Survivor CarePreventive Care
Hematology NewsNew Tools for Monitoring Multiple MyelomaJuly 3, 2024Multiple MyelomaPatient & Survivor Care
Oncology PracticeEMA Greenlights Four Drugs for Bladder and Other CancersJuly 2, 2024Genitourinary CancerPatient & Survivor CareLeukemia, Myelodysplasia, TransplantationCMLNon-Hodgkin LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeMUC-1 vaccine associated with notable overall survival rates in breast cancerJune 27, 2024Breast CancerPatient & Survivor CareImmunotherapyImmuno-oncologyLung Cancer
